bioRxivMolecular BiologyPreprint
The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion in experimental diabetic kidney disease via promotion of endoplasmic reticulum stress
Aowen ZhuangiD, Felicia Y. T. Yap, Domenica A. McCarthy, Sally A. Penfold, Karly C. Sourris, Melinda T. CoughlaniD, Benjamin Luke SchulziD, Josephine Maree ForbesiD
Abstract
The accumulation of advanced glycation end products is implicated in the development and progression of diabetic kidney disease. No study has examined whether stimulating advanced glycation clearance via receptor manipulation is reno-protective in diabetes. Podocytes, which are early contributors to diabetic kidney disease and could be a target for reno-protection. To examine the effects of increased podocyte oligosaccharyltransferase-48 on kidney function, glomerular sclerosis, tubulointerstitial fibrosis and proteome (PXD011434), we generated a mouse with increased oligosaccharyltransferase-48kDa subunit abundance in podocytes driven by the podocin promoter. Despite increased urinary clearance of advanced glycation end products, we observed a decline in renal function, significant glomerular damage including glomerulosclerosis, collagen IV deposition, glomerular basement membrane thickening and foot process effacement and tubulointerstitial fibrosis. Analysis of isolated glomeruli identified enrichment in proteins associated with collagen deposition, endoplasmic reticulum stress and oxidative stress. Ultra-resolution microscopy of podocytes revealed denudation of foot processes where there was co-localization of oligosaccharyltransferase-48kDa subunit and advanced glycation end-products. These studies indicate that increased podocyte expression of oligosaccharyltransferase-48kDa subunit results in glomerular endoplasmic reticulum stress and a decline in kidney function.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion.
Aowen Zhuang, Felicia Y. T. Yap, … Josephine Maree Forbes·Scientific ReportsPeer-reviewed·Sep 20, 2019
- Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease
S. P. Srivastava, H. Zhou, … J. E. Goodwin·bioRxiv·Nov 8, 2023
- Endothelial Kallikrein-Related Peptidase 8 Promotes Diabetic Nephropathy through a LIFR dependent mechanism
Jiankui Du, Mingyang Li, … Xin Ni·bioRxiv·Jul 1, 2025
- Claudin-1 Inhibitor PDS-0330 Ameliorates Diabetic Kidney Disease by Suppressing Src/Akt/mTOR Signaling Pathway in Podocytes
Kazuhiko Fukushima, Kenji Tsuji, … Jun Wada·bioRxiv·Dec 26, 2025
- Metabolic reprogramming by endothelial ANGPTL4 depletion protects against diabetic kidney disease
Swayam Prakash Srivastava, Han Zhou, … Julie E. Goodwin·bioRxiv·May 8, 2025
- High glucose-induced ubiquitylation of G6PD leads to the injury of podocyte
Meng Wang, Ji Hu, … Zhaoyun Zhang·bioRxiv·Jun 20, 2018